Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and IgA Vasculitis

erlotinib hydrochloride has been researched along with IgA Vasculitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatsuse, M; Morihara, K; Murakami, S; Nagata, K; Okano, A; Shimazaki, C; Shiotsu, S; Yuba, T1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and IgA Vasculitis

ArticleYear
[Henoch-schönlein purpura induced by erlotinib (Tarceva): a case report].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:1

    Topics: Adenocarcinoma; Aged; Erlotinib Hydrochloride; Female; Humans; IgA Vasculitis; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines

2010